---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-022569"
form_type: "8-K"
ticker: "STOK"
cik: "0001623526"
company_name: "Stoke Therapeutics, Inc."
filed_at: "2026-01-26T23:59:59+00:00"
generated_at: "2026-05-16T07:57:13.117121+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Stoke Therapeutics enters $85.5M lease for 98,500 sq ft Waltham HQ/lab through 2038

## Summary
- New lease with NWALP PHOP Property Owner LLC for 98,500 sq ft at 245 Fifth Avenue, Waltham, MA.
- Aggregate base rent ~$85.5M over term ending March 31, 2038; two five-year extension options at market rate.
- Security deposit of $3M in form of irrevocable standby letter of credit, reducible over time.
- Lease supports expansion of corporate headquarters and laboratory space.

## SEC filing metadata
- accession: 0001193125-26-022569
- form_type: 8-K
- ticker: STOK
- cik: 0001623526
- company_name: Stoke Therapeutics, Inc.
- filed_at: 2026-01-26T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 2.03
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1623526/000119312526022569/0001193125-26-022569-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1623526/000119312526022569/d100412d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-022569
- JSON: https://secwatch.observer/filing/0001193125-26-022569.json
- Plain text: https://secwatch.observer/filing/0001193125-26-022569.txt

## Key facts
- Material Agreements
  Stoke Therapeutics, Inc. entered into Lease Agreement with NWALP PHOP Property Owner LLC valued at approximately 98,500 square feet (effective 2026-01-21).
  - Action: entry
  - Agreement: lease
  - Counterparty: NWALP PHOP Property Owner LLC
  - Value: approximately 98,500 square feet
  - Effective: 2026-01-21
  source text: On January 21, 2026, Stoke Therapeutics, Inc. (the “Company”) entered into a new lease for its corporate headquarters and laboratory with NWALP PHOP Property Owner LLC, located at 245 Fifth Avenue, Waltham, Massachusetts (the “Lease Agreement”), in order to expand its office and laboratory space.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1623526/000119312526022569/0001193125-26-022569-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.